Liu Chunyan, Shao Zonghong
Department of Hematology, General Hospital of Tianjin Medical University, Tianjin 300052, China.
J Transl Int Med. 2018 Oct 9;6(3):134-137. doi: 10.2478/jtim-2018-0028. eCollection 2018 Sep.
Aplastic anemia (AA) is a hematologic disease characterized by pancytopenia. Up to now, severe aplastic anemia (SAA) has been recognized by international and domestic scholars as an autoimmune disease with bone marrow (BM) failure mediated by the hyperfunctional T lymphocytes. The incidence of AA is more in China compared with other countries. In the recent years, both the pathogenesis and treatment of AA have made a great progress in our country. Thus, the therapeutic effect of AA was much better than before. Here, we conclude the researches of AA in China.
再生障碍性贫血（AA）是一种以全血细胞减少为特征的血液系统疾病。迄今为止，重型再生障碍性贫血（SAA）已被国际和国内学者公认为是一种由功能亢进的T淋巴细胞介导的骨髓衰竭的自身免疫性疾病。与其他国家相比，AA在中国的发病率更高。近年来，我国在AA的发病机制和治疗方面均取得了很大进展。因此，AA的治疗效果比以前要好得多。在此，我们总结了国内关于AA的研究。
